Free Subscription to CFO Magazine

You are here: Home : Chart

The CFO-PRTM Capital-Spending Scorecard
Companies with the biggest and the smallest returns on capital investment.
CFO Staff, CFO Magazine




Pharmaceuticals
COMPANY CAPEX
(2003)
CAPEX CAGR
(2000-2003)
CAPITAL INTENSIVENESS
(2003)
ROGFA
(2003)
REVENUE GROWTH
(CAGR 2000-2003)
SHAREHOLDER GROWTH
(2000-2003)
AMGEN $1,356,800,000 46% 16% 80% 32% -1%
JOHNSON & JOHNSON $2,262,000,000 11% 5% 79% 13% 1%
TAKEDA PHARMACEUTICAL $303,742,684 -2% 3% 78% 4% -14%
BRISTOL-MYERS SQUIBB $937,000,000 17% 4% 62% 5% -25%
GLAXOSMITHKLINE $1,572,497,756 -5% 4% 62% 6% -10%
AVENTIS $1,403,810,694 -23% 6% 60% -7% -17%
NOVARTIS $1,420,892,255 9% 5% 59% -2% -6%
MERCK $1,915,900,000 -11% 9% 49% -18% -19%
ASTRAZENECA $1,409,860,375 -4% 7% 48% 3% -6%
ROCHE $1,809,882,277 1% 7% 39% 3% -8%
ELI LILLY $1,706,600,000 36% 14% 38% 5% -7%
PFIZER $2,641,000,000 6% 6% 37% 15% -7%
ABBOTT LABS $1,246,741,000 6% 6% 36% 13% 1%
YAMANOUCHI PHARMACEUTICAL $165,340,470 -9% 4% 34% 5% -18%
SUZUKEN $27,019,915 -30% 0% 32% 7% 10%
SCHERING $390,903,503 3% 7% 30% 2% -11%
WYETH $1,908,661,000 4% 12% 29% 6% -11%
MERCK KGAA $345,175,169 -13% 4% 23% 2% -9%
SANKYO $149,979,585 -22% 3% 21% -1% -14%
SCHERING PLOUGH $701,000,000 -3% 8% 6% -5% -31%
Average Performance $1,183,740,334 1% 6.6% 45% 4% -10%
Median Performance $1,380,305,347 0% 6.1% 38% 4% -9%

Companies are ranked, from highest to lowest, by return on gross fixed assets (ROGFA).

Sources: Thomson Financial; company data; Pittiglio Rabin Todd & McGrath.

Return to "Capital Choices"



Page 13 of 16
previous previous 10 pages 11 12 13 14 15 16
 

Email to a Colleague   Printer Friendly Version  

ad